AEDG Peptide (Epitalon) Stimulates Gene Expression and Protein Synthesis during Neurogenesis: Possible Epigenetic Mechanism.

Mechanism / theoretical grounding — not clinical validation.

Khavinson V, Diomede F, Mironova E, Linkova N, Trofimova S, Trubiani O, Caputi S, Sinjari B. Molecules. 2020.

Organ: brain-cognition · Type: in-vitro · Peptides: Epitalon

PMID: 32019204

In human gingival mesenchymal stem cells, AEDG (Epitalon) raised nestin, GAP43, β-tubulin III, and doublecortin mRNA and protein; histone docking is offered as a possible epigenetic mechanism, not a clinical result.

Editorial summary of a 2020 original article in Molecules (MDPI, open access: doi:10.3390/molecules25030609). Culture work plus molecular modelling. Public pages cite PubMed; the DOI is the OA record. Read the paper: PMID 32019204.

Methods

Human gingival mesenchymal stem cells (hGMSCs) treated with the tetrapeptide AEDG (Ala-Glu-Asp-Gly, Epitalon). The authors measured neurogenic differentiation markers — nestin, GAP43, β-tubulin III, and doublecortin — at protein and mRNA levels. Separately they used molecular modelling to dock AEDG onto histones H1/6 and H1/3. Culture media, peptide concentrations, and n belong in the primary text.

Findings

The authors report that AEDG increased synthesis of those four markers and increased their mRNA by 1.6–1.8 times in hGMSCs. Modelling preferred binding at His-Pro-Ser-Tyr-Met-Ala-His-Pro-Ala-Arg-Lys on H1/6 and H1/3 and at Tyr-Arg-Lys-Thr-Gln, sites the authors say interact with DNA. They interpret histone contact as one possible way AEDG could raise transcription of neuronal-differentiation genes.

This is a single stem-cell and docking paper. It is not evidence that Epitalon induces neurogenesis in patients. Follow the PMID and the OA DOI.